Nov. 10, 2022— It is safe to say the 340B drug pricing program would not be what it is today without former Congressman Henry Waxman. In fact, 340B might not even exist. As chairman of the key congressional committee with jurisdiction over health care programs, the California Democrat was the lead author of the legislation that created 340B in 1992. To mark the 30th anniversary … [Read more...]
Minnesota’s Largest Newspaper Explores How CMS Proposed Rule Would Hurt 340B Hospitals and Patients
September 25, 2017—Regulations proposed by the Trump administration could significantly weaken the 340B drug discount program, with programs for low-income or vulnerable patients taking the biggest hit, a 2013 Pulitzer Prize-winner writes in a front-page article in today’s Minneapolis Star-Tribune. … [Read more...]
NPR and Kaiser Health News Explore 340B Orphan Drug Exclusion
September 18, 2017—National Public Radio and Kaiser Health News have collaborated on an in-depth report on how a federal law that denies rural hospitals 340B drug discounts on orphan drugs “has left rural hospital pharmacists and health care workers struggling to keep medicines in stock, and wondering if they will be able to adequately care for patients.” … [Read more...]